LINC00052 upregulates EPB41L3 to inhibit migration and invasion of hepatocellular carcinoma by binding miR-452-5p.
Zhu L, Yang N, Chen J, Zeng T, Yan S, Liu Y, Yu G, Chen Q, Du G, Pan W, Li X, Zhou H, Huang A, Tang H.
Zhu L, et al. Among authors: yan s.
Oncotarget. 2017 Jun 29;8(38):63724-63737. doi: 10.18632/oncotarget.18892. eCollection 2017 Sep 8.
Oncotarget. 2017.
PMID: 28969024
Free PMC article.